News
12 Health Care Stocks Moving In Friday's Intraday Session
29 Mar 24
Movers
12 Health Care Stocks Moving In Friday's Pre-Market Session
29 Mar 24
Movers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
28 Mar 24
Movers
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
27 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Wednesday's Intraday Session
27 Mar 24
Movers
Earnings Scheduled For March 26, 2024
26 Mar 24
Earnings
Lucid Diagnostics Provides Business Update; Reports Q4 EsoGuard Revenue Of $1.04M, Up 33% Sequentially
25 Mar 24
Earnings, News
Preview: PAVmed's Earnings
25 Mar 24
Earnings
Lucid Diagnostics Announces Data From The First Prospective Clinical Validation Study Of EsoGuard Esophageal Precancer Testing In A Screening Population
21 Mar 24
Biotech, News, General
Press releases
Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
8 Apr 24
Press Releases
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
26 Mar 24
Earnings, Press Releases
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results
25 Mar 24
Earnings, Press Releases
Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population
21 Mar 24
Press Releases
PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX
21 Mar 24
Press Releases
Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference
20 Mar 24
Press Releases
PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024
13 Mar 24
Press Releases
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024
12 Mar 24
Small Cap, Press Releases
Lucid Diagnostics Provides Update Regarding World Trade Center Health Program
16 Feb 24
Press Releases
Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony
15 Feb 24
Press Releases
Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors
8 Feb 24
News, Contracts, Press Releases